Xtx Topco LTD Ironwood Pharmaceuticals Inc Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.32 - $15.45 $76,652 - $142,340	9,213 Added 19.84%	55,658 $484,000
Q4 2023 Feb 13, 2024	BUY	$8.79 - $11.51 $267,497 - $350,272	30,432 Added 190.05%	46,445 $531,000
Q3 2023 Nov 13, 2023	SELL	$8.25 - $11.35 $285,763 - $393,141	-34,638 Reduced 68.39%	16,013 $154,000
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $511,575 - $587,551	50,651 New	50,651 $538,000
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $384,650 - $442,783	34,810 New	34,810 $401,000
Q2 2021 Aug 12, 2021	SELL	$10.16 - $13.11 $139,171 - $179,580	-13,698 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$9.04 - $11.86 $123,829 - $162,458	13,698 New	13,698 $153,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $679M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.